Nicholas S. Britt

Nicholas Britt
  • Associate Professor
  • Department of Pharmacy Practice
  • KUMC - Internal Medicine

Contact Info

913-588-5391
University of Kansas Hospital, Wescoe 6010
Medical Center, Kansas City
3901 Rainbow Boulevard
Kansas City, KS 66160

Personal Links

Biography —

Dr. Britt joined the faculty at the University of Kansas School of Pharmacy in August 2017. He is actively involved in clinical and translational research at the University of Kansas Medical Center and the Veterans Health Administration, where he holds a joint research appointment. Dr. Britt maintains an active clinical practice site on the inpatient infectious diseases consult service at the University of Kansas Hospital.

Professional Experience

  • Assistant Professor of Pharmacy Practice, University of Kansas, Lawrence, KS (2017 - present)
  • Assistant Professor of Internal Medicine, University of Kansas Medical Center, Kansas City, KS (2017 - present)
  • Clinical Pharmacist, Infectious Diseases, University of Kansas Hospital, Kansas City, KS (2017 - present)
  • Pharmacy Research Staff, Dwight D. Eisenhower Veterans Affairs Medical Center, Leavenworth, KS (2015 - present)

Education —

Infectious Diseases Pharmacy Residency, Barnes-Jewish Hospital, 2017, St. Louis, MO
Pharmacy Practice Residency, Barnes-Jewish Hospital, 2016, St. Louis, MO
Pharm.D., University of Kansas School of Pharmacy, 2015, Lawrence, KS
M.S. in Clinical and Translational Research, University of Kansas School of Medicine, 2014, Kansas City, KS
B.S. in Pharmaceutical Studies, University of Kansas School of Pharmacy, 2013, Lawrence, KS

Research —

The Britt lab works along the clinical-translational science continuum to optimize the treatment of infectious diseases and sepsis. We use traditional in vitro pharmacokinetic (PK)/pharmacodynamic (PD) models of infection, as well as novel tools developed in our laboratory to identify more effective therapeutic strategies for combating multidrug-resistant infections. In addition, we study how the immune system responds to severe infection and how it can be modulated to improve patient outcomes.

Research Interests

  • Infectious Diseases
  • Immunology
  • Sepsis
  • Cystic Fibrosis

Teaching —

Courses Taught

  • PHPR 624 - Pharmacoepidemiology and Public Health
  • PHPR 663 - Pharmacotherapy III
  • PHPR 665 - Pharmacotherapy V

Rotations

  • Infectious Diseases (General) - Inpatient Consult Service (APPE)
  • Clinical and Translational Research in Infectious Diseases (APPE)

Selected Publications —

Britt NS, Ritchie DJ, Kollef MH, et al. Importance of site of infection and antibiotic selection in the treatment of carbapenem-resistant Pseudomonas aeruginosa sepsis. Antimicrob Agents Chemother. 2018 Mar 27;62(4).

Britt NS, Potter EM, Patel N, Steed ME. Comparative Effectiveness and Safety of Standard-, Medium-, and High-Dose Daptomycin Strategies for the Treatment of Vancomycin-Resistant Enterococcal Bacteremia Among Veterans Affairs Patients. Clin Infect Dis. 2017 Mar 1;64(5):605-13.

Britt NS, Patel N, Horvat RT, Steed ME. Vancomycin 24-Hour Area under the Curve/Minimum Bactericidal Concentration Ratio as a Novel Predictor of Mortality in Methicillin-Resistant Staphylococcus aureus Bacteremia. Antimicrob Agents Chemother. 2016 Apr 22;60(5):3070-5.

Britt NS, Potter EM, Patel N, Steed ME. Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients. Clin Infect Dis. 2015 Sep 15;61(6):871-8.

**Society of Infectious Diseases Pharmacists Pharmacotherapy Impact Paper of the Year (2016)

**ASHP Foundation Research Award (2016)

Awards & Honors —

  • American Society of Microbiology Infectious Diseases Fellow (2017)
  • ASHP Foundation Research Award (2016)
  • St. Louis College of Pharmacy Research Award (2016)